Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 25 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 2
7(33.3%)
N/A
6(28.6%)
Phase 3
3(14.3%)
Phase 1
2(9.5%)
Phase 4
2(9.5%)
Early Phase 1
1(4.8%)
21Total
Phase 2(7)
N/A(6)
Phase 3(3)
Phase 1(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT07409298Not ApplicableEnrolling By Invitation

Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy

Role: collaborator

NCT06107582Recruiting

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

Role: collaborator

NCT07111429Not Yet Recruiting

Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI Classification

Role: collaborator

NCT07075250Phase 4Not Yet Recruiting

Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study

Role: collaborator

NCT07063225Phase 2Recruiting

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

Role: collaborator

NCT05236582Phase 2Recruiting

Herombopag for Chemotherapy-induced Thrombocytopenia

Role: collaborator

NCT05218226Phase 2Recruiting

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Role: collaborator

NCT04600960Phase 2Recruiting

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Role: collaborator

NCT06772311Not Yet Recruiting

Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit

Role: collaborator

NCT06199089Phase 2Active Not Recruiting

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Role: collaborator

NCT06678711Not ApplicableNot Yet Recruiting

Minimally Invasive Atlantoaxial Lateral Mass Joint Fusion (MIS-PALF) As a Surgical Treatment of Atlantoaxial Dislocation

Role: collaborator

NCT05718856Phase 4Recruiting

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Role: collaborator

NCT04937803Not ApplicableCompleted

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

Role: collaborator

NCT06285136Phase 2Not Yet Recruiting

Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult

Role: collaborator

NCT05847270Not ApplicableRecruiting

Surgical Treatment of Irreducible Atlantoaxial Dislocation

Role: collaborator

NCT05949762Phase 1Unknown

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

Role: collaborator

NCT05893472Phase 1Unknown

A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.

Role: collaborator

NCT05159947Phase 3Unknown

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial

Role: collaborator

NCT03692663Early Phase 1Unknown

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Role: collaborator

NCT04850027Unknown

MRI-guided Lateral Lymph Node Dissection in Rectal Cancer

Role: collaborator